Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab

Bevacizumab is a recombinant humanized monoclonal antibody and a key drug for treatment of various types of cancer. Bevacizumab is associated with the occurrence of heart failure, but its risk factors remain unknown. A 55-year-old woman was diagnosed with cervical cancer, which was completely treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumida, Toshihide, Imamura, Teruhiko, Ueno, Yohei, Fukahara, Kazuaki, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539381/
https://www.ncbi.nlm.nih.gov/pubmed/34684038
http://dx.doi.org/10.3390/medicina57100998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539381/
https://www.ncbi.nlm.nih.gov/pubmed/34684038
http://dx.doi.org/10.3390/medicina57100998

Ejemplares similares